 omnipod sale crush number dash releas channel shift
grow demand diabet pt
predict time earli may upgrad
seem benefit varieti strong growth driver keep
compani meaning exceed street expect combin dash
platform no-commit adopt model payor coverag move toward
pharmaci channel greater eas access patient payor
strong growth diabet market seem fuel podd impress
growth patient enthusiasm diabet technologyinclud
insulin pumpsseem mountingsom might even say time
ridicul unusu new medic technolog feel abbott neutral
push reluct endocrinologist embrac technolog
continu massiv buoy effect player believ podd rais
guidanc look achiev littl direct competit patch pump
market well excit product pipelin like posit vs diabet
devic stock rais pt use multipl
feel bit like broken record continu churn
hit thank factor weve mention past note expect
strong continu growth next quarter tough comp mid-
give us paus think excit around slate horizon launch
late may help boost adopt omnipod around time
guidanc move higher midpoint
point manag confid potenti inflect point seen
 omnipod sale quarter continu model top end
rang intern omnipod busi move
sale outlook outyear higher well
gross margin weak expect remain dampen
product new manufactur plant get underway second
manufactur line expect instal later year use
product dynam fade
valuat pt base month revenu forecast risk
discuss
idc btig estim compani document
million except per share amount
like differenti omnipod tubeless insulin deliveri lower up-front cost potenti new
reimburs opportun potenti drug deliveri upsid compani improv gross margin
grown instal base continu grow despit competit target mdi patient first
time pumper simpl dispos devic think go patient group medtron
buy pt dash platform improv patient experi longer term horizon
expand product offer want autom insulin deliveri
updat dash adopt shift pharmaci channel payor coverag
horizon loop trial regulatori updat
competit launch autom insulin deliveri system
announc new drug deliveri product
strong clinic data horizon and/or loop system
increas adopt diabet technolog
improv gross margin oper margin
revenu growth rate meaning higher
explos growth adopt diabet technolog favor simpl
acceler improv gross margin oper margin
significantli better clinic data horizon and/or loop vs competit
revenu growth rate meaning lower
slow adopt diabet technolog
littl improv gross margin oper margin
disappoint clinic data horizon and/or loop system
insulet corpor make sell
proprietari omnipod insulin
omnipod worn
bodi approxim three day
time convent insulin
pump requir patient learn
use manag wear number
includ inch tube
contrast omnipod system
devic elimin need
bulki pump tube separ
blood glucos meter provid
wirelessli integr blood
top total revenu forecast thank out-performance omnipod revenu
beat intern omnipod sale beat drug deliveri revenu gross margin bp lower
model compani continu expand manufactur capac sg spend well control come
combin bp estim off-set spend bp forecast net
oper margin bp project impact higher interest/oth expens contribut eight cent
miss ep
updat forecast strong perform particularli omnipod busi revis
revenu outlook account compani guidanc new ou omnipod revenu estim land top
end guidanc rang drug deliveri revenu forecast hit near midpoint rang
actualsbtig estimate varianceu omnipod omnipod deliveri spend spend spend oper btig estim compani filingsvari
rest increas omnipod outlook tweak ou omnipod slightli nudg drug
deliveri sale higher adjust result updat total revenu estim guidanc rang
chang outyear omnipod revenu estim increas meaning ou revenu
estim move slightli higher drug deliveri sale project rel unchang overal total revenu
estim increas
 decreas gross margin reflect commentari manufactur ramp gross margin
outyear remain rel unchang prior model adjust oper spend reflect higher level
invest tweak spend lower bit higher model non-gaap ep model reflect
manag commentari margin metric
insulet rate buy increas pt base month revenu forecast
share trade line multipl ntm revenu estim believ multipl fast-
grow med-tech comp group high-growth diabet technolog compani deserv
podd robust revenu ramp grow patient awar diabet technolog favor shift payor
pharmaci channel dynam product pipelin risk rate price target includ disrupt
intern revenu instal patient base increas competit potenti prefer partnership
major insur group lack visibl next drug deliveri product
bpsebit bp btig estim compani filingsnewold changentm inc ingnnot diabetestndmnot medicalwmginot factset data btig estimatespr ex-amortcompanytickerr ptpricemarket cap
incom statement adjust nd etot revenu y/i growth adjust neighborhood good oper expens tax expens net incom share net incom adjustments- gaap net incom gaap ep growth y/ymarginsgross incomenmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnet incomenmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmexpensescog oper expens quarterli result growth rate adjust neighborhood divestituresourc btig estim compani report
revenu etot revenu omnipod y/i omnipod y/i deliveri y/i revenu exclud neighborhood y/i growth adjust neighborhood revenu omnipod revenu breakdownbegin instal new patient start patient y/i patient attrit instal instal base average es order per re-ord annual new user quarterli annual asp new patient revenu new user total omnipod y/i productivity/rep omnipod revenu breakdownbegin instal new patient patient y/i patient attrit instal instal base average es order per re-ord quarterli annual asp new user quarterli annual asp new patient new user total omnipod y/i deliveri revenuesymphoni health data forecast neulasta syring neulsasta onpro total neulasta y/i estim neulasta sale attribut onpro neulasta sale attribut onpro deliverynmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnmnm total neulasta onpro end-us neulasta onpro impli neulasta onpro total neulasta onpro total neulasta onpro revenu total neulasta onpro drug total report drug deliveri sourc btig estim compani report symphoni health solut symphoni health symphoni health b/c btig estim report drug deliveri revenu /f btig estim
btig cover compani mention report
appendix analyst certif import disclosur
